Literature DB >> 24756098

Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice.

Hari K Somineni1, Gregory P Boivin, Khalid M Elased.   

Abstract

Angiotensin II (Ang II) is involved in induction and progression of renal damage in diabetes. Angiotensin converting enzyme 2 (ACE2) is highly expressed in the kidney and has been shown to be renoprotective by degrading Ang II to Ang-(1-7). A disintegrin and metalloproteinase 17 (ADAM17)-mediated shedding of renal ACE2 contribute to diabetic nephropathy pathogenesis. Lifestyle modification and metformin are recommended as initial therapies for most patients with type 2 diabetes. The aim of this study was to investigate whether exercise training and/or metformin improve glucose homeostasis and albuminuria and downregulate renal ADAM17 and ACE2 shedding in db/db mice. Seven-week-old normal and db/db mice were subjected either to a sedentary existence or exercise training with and without metformin (150 mg/kg per day) for 10 weeks. Exercise training significantly lowered blood glucose, urinary albumin and ACE2 excretion in db/db mice. ADAM17 and ACE2 proteins were co-localized in cortical tubules of the kidney, indicating a possible interaction. Metformin treatment was effective in lowering hyperglycemia only during the first 2 weeks of treatment. Increased renal ADAM17 in 17-week-old db/db mice was corrected by physical exercise but not metformin. In addition, exercise training reduced plasma triglycerides and enhanced insulin levels of db/db mice. In conclusion, exercise training alone and in combination with metformin prevented shedding of renal ACE2 by decreasing ADAM17 protein. Urinary ACE2 could serve as a prognostic tool for the progression of kidney damage and its attenuation by exercise may partially contribute to its renal protection.

Entities:  

Keywords:  ADAM17; diabetic nephropathy; exercise; metformin; type 2 diabetes; urinary ACE2

Mesh:

Substances:

Year:  2014        PMID: 24756098      PMCID: PMC4004628          DOI: 10.1530/JOE-13-0532

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  72 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Exercise-induced proteinuria?

Authors:  Fahad Saeed; Pardha Naga Pavan Kumar Devaki; Lokesh Mahendrakar; Jean L Holley
Journal:  J Fam Pract       Date:  2012-01       Impact factor: 0.493

3.  What's preventing us from preventing type 2 diabetes?

Authors:  Judith E Fradkin; B Tibor Roberts; Griffin P Rodgers
Journal:  N Engl J Med       Date:  2012-09-27       Impact factor: 91.245

4.  Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Authors:  Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reuben Andres; Christopher Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

5.  Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

Authors:  Minghao Ye; Jan Wysocki; Josette William; Maria José Soler; Ivan Cokic; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2006-10-04       Impact factor: 10.121

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

7.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

8.  Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy.

Authors:  G Wang; F M-M Lai; K-B Lai; K-M Chow; C-H B Kwan; K-T P Li; C-C Szeto
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

9.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

10.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

View more
  13 in total

Review 1.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

2.  Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in COS7 cells.

Authors:  Nadja Grobe; Mauricio Di Fulvio; Nada Kashkari; Harshita Chodavarapu; Hari K Somineni; Richa Singh; Khalid M Elased
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-04       Impact factor: 4.249

3.  Chymase-dependent production of angiotensin II: an old enzyme in old hearts.

Authors:  Ghezal Froogh; John T Pinto; Yicong Le; Sharath Kandhi; Yeabsra Aleligne; An Huang; Dong Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-04       Impact factor: 4.733

4.  Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.

Authors:  Sridevi Gutta; Nadja Grobe; Meenasri Kumbaji; Hassan Osman; Mohammad Saklayen; Gengxin Li; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-21

Review 5.  Influence of exercise training on diabetic kidney disease: A brief physiological approach.

Authors:  Liliany Souza de Brito Amaral; Cláudia Silva Souza; Hernando Nascimento Lima; Telma de Jesus Soares
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

6.  Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice.

Authors:  Laale F Alawi; Sana E Emberesh; Brenda A Owuor; Harshita Chodavarapu; Rucha Fadnavis; Salim S El-Amouri; Khalid M Elased
Journal:  Physiol Rep       Date:  2020-02

Review 7.  Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.

Authors:  Murat Oz; Dietrich Ernst Lorke
Journal:  Biomed Pharmacother       Date:  2021-01-05       Impact factor: 6.529

8.  Glomerular Endothelial Cells Are the Coordinator in the Development of Diabetic Nephropathy.

Authors:  Tingting Li; Kaiyuan Shen; Jiawei Li; Susan W S Leung; Tongyu Zhu; Yi Shi
Journal:  Front Med (Lausanne)       Date:  2021-06-18

9.  Type 2 Diabetes Leads to Axon Initial Segment Shortening in db/db Mice.

Authors:  Leonid M Yermakov; Domenica E Drouet; Ryan B Griggs; Khalid M Elased; Keiichiro Susuki
Journal:  Front Cell Neurosci       Date:  2018-06-08       Impact factor: 5.505

Review 10.  The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.

Authors:  Sahar Najafi; Elham Rajaei; Rezvan Moallemian; Forough Nokhostin
Journal:  Clin Rheumatol       Date:  2020-09-03       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.